Trump administration plans to end a Medicare drug-plan premium subsidy
Current reporting says CMS will end a Medicare Part D premium-stabilization subsidy after 2026, a change that could raise drug-plan premiums for many older adults in 2027 and invite congressional oversight. (sources: theguardian, www.cms.gov, www.wsj.com)
The administration intends to end a premium subsidy for Medicare drug plans, with reports estimating the potential impact on premiums. The decision is part of broader policy changes under consideration.
- The subsidy is set to end after 2026.
- Reports indicate that this change may affect drug plan premiums.
Why it matters
The termination of the subsidy could have significant implications for Medicare beneficiaries and their drug plan costs.
Connected public decisions
Follow the issue pages where this story connects to public action.
Contact officials
Act on Prescription drug prices
See the current decision, choose your position, and send a message through the issue page.
Take action on Prescription drug prices